Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of polyneuropathy during thalidomide therapy.

C H Wulff, H Høyer, G Asboe-Hansen

    The British Journal of Dermatology
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Fatigue after head and neck cancer-results of a survey using the Multidimensional Fatigue Inventory (MFI-20)].

    HNO·2020
    Same author

    Intraoperative reduction of vasopressors using processed electroencephalographic monitoring in patients undergoing elective cardiac surgery: a randomized clinical trial.

    Journal of clinical monitoring and computing·2019
    Same author

    Variants in the genes DCTN2, DNAH10, LRIG3, and MYO1A are associated with intermediate Charcot-Marie-Tooth disease in a Norwegian family.

    Acta neurologica Scandinavica·2015
    Same author

    Heart rate variability - a potential early marker of sub-acute post-stroke infections.

    Acta neurologica Scandinavica·2011
    Same author

    Genetic epidemiology of Charcot-Marie-Tooth in the general population.

    European journal of neurology·2010
    Same author

    Seroprevalence of influenza A and B in German infants and adolescents.

    Medical microbiology and immunology·2009

    Long-term thalidomide use caused severe sensory peripheral neuropathy in patients with prurigo nodularis and aphthous stomatitis. Despite dramatic dermatological improvement, neurotoxicity necessitates short-term thalidomide treatment.

    Area of Science:

    • Neurology
    • Dermatology
    • Clinical Pharmacology

    Background:

    • Prurigo nodularis and aphthous stomatitis are debilitating skin conditions.
    • Thalidomide is an effective treatment for certain dermatological disorders.
    • The long-term safety profile of thalidomide, particularly neurotoxicity, requires further investigation.

    Purpose of the Study:

    • To evaluate the neurotoxic effects of long-term thalidomide administration.
    • To assess the efficacy and safety of thalidomide in patients with prurigo nodularis and aphthous stomatitis.

    Main Methods:

    • Case series involving eight patients (seven with prurigo nodularis, one with aphthous stomatitis).
    • Patients received thalidomide at doses ranging from 40-115 g for 1 to 6 years.
    • Clinical assessment of neuropathy and dermatological symptoms, including nerve conduction studies.

    Related Experiment Videos

    Main Results:

    • All patients developed predominantly sensory peripheral neuropathy, primarily affecting the lower limbs.
    • Nerve conduction studies indicated axonal neuropathy with small sensory action potentials.
    • Significant improvement in dermatological conditions was observed, but treatment was discontinued due to severe neuropathy.

    Conclusions:

    • Long-term thalidomide use is associated with significant sensory peripheral neurotoxicity.
    • While effective for dermatological conditions, thalidomide's neurotoxic effects limit its prolonged use.
    • Short-term administration of thalidomide is recommended to mitigate the risk of severe side-effects.